天康生物 (002100.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(天康生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 13,087,153,128.587,993,043,517.913,776,851,559.4119,025,806,286.5914,705,995,884.828,963,149,801.463,890,843,979.48
 营业收入(元) 13,087,153,128.587,993,043,517.913,776,851,559.4119,025,806,286.5914,705,995,884.828,963,149,801.463,890,843,979.48
二、营业总成本(元) 12,617,293,868.827,789,522,484.273,678,286,988.7519,995,177,780.1415,185,082,263.259,367,051,782.513,865,300,990.35
 营业成本(元) 11,518,612,004.777,074,450,248.553,309,034,521.0018,469,448,818.7214,102,713,411.338,673,203,407.283,549,707,162.09
 研发费用(元) 249,626,186.54154,290,133.7466,463,953.07257,231,957.14178,179,797.1298,737,400.7040,156,984.48
 营业税金及附加(元) 33,021,523.2021,706,298.7610,091,810.9746,798,758.4433,248,413.2721,117,941.649,863,979.35
 销售费用(元) 353,352,827.23233,330,190.16129,381,097.22543,057,284.05390,582,458.45249,046,818.36106,983,141.48
 管理费用(元) 345,479,562.81223,811,636.83121,771,424.11486,689,243.15323,158,998.31218,252,469.31104,830,863.20
 财务费用(元) 117,201,764.2781,933,976.2341,544,182.38191,951,718.64157,199,184.77106,693,745.2253,758,859.75
  其中:利息费用(元) 137,878,753.2795,463,022.9346,516,782.00245,538,688.85199,671,196.92139,179,255.5170,835,550.29
  其中:利息收入(元) 28,568,918.1619,724,310.437,987,156.8757,478,828.2344,012,171.9030,063,007.8415,057,085.67
三、其他经营收益
 加:公允价值变动收益(元) 72,374.0248,766.16-448.68-3,530.44-12,170.00-122,110.0015,270.00
 加:投资收益(元) -213,767.38-1,149,498.281,098,553.293,459,929.483,557,400.481,529,523.041,139,551.82
  其中:对联营企业和合营企业的投资收益(元) -2,548,999.77-2,277,224.781,098,553.29-271,230.271,619,816.991,293,073.181,139,551.82
 资产处置收益(元) 2,266,143.89878,022.72-3,898,306.205,989,878.76-5,332,481.88-2,711,470.56
 资产减值损失(元) 95,718,626.1396,341,988.33-1,061,930.70-500,193,049.85-49,364,048.98-47,383,933.55-
 信用减值损失(元) -29,898,067.63-16,973,222.79-19,011,981.18-53,203,203.11-50,654,794.28-40,164,295.23-21,500,860.35
 其他收益(元) 49,596,015.5534,676,656.1810,963,408.0169,375,420.6236,053,238.8713,229,810.378,345,527.01
四、营业利润(元) 587,400,584.34317,343,745.9690,552,171.40-1,446,037,620.65-533,516,873.58-482,145,468.3010,831,007.05
 加:营业外收入(元) 18,700,553.23694,084.89322,058.522,757,432.381,648,191.31498,164.59262,711.97
 减:营业外支出(元) 34,113,120.1124,240,518.8012,973,862.2549,687,990.1335,321,148.2816,875,435.017,142,300.50
五、利润总额(元) 571,988,017.46293,797,312.0577,900,367.67-1,492,968,178.40-567,189,830.55-498,522,738.723,951,418.52
 减:所得税费用(元) 17,492,247.8814,031,521.4717,724,158.5023,459,155.9221,611,408.8921,841,669.6521,100,463.83
六、净利润(元) 554,495,769.58279,765,790.5860,176,209.17-1,516,427,334.32-588,801,239.44-520,364,408.37-17,149,045.31
(一)按经营持续性分类
  持续经营净利润(元) 554,495,769.58279,765,790.5860,176,209.17-1,516,427,334.32-588,801,239.44-520,364,408.37-17,149,045.31
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 565,624,390.53276,682,923.9454,063,760.85-1,363,316,030.34-504,382,106.12-447,288,636.14-14,282,251.76
  少数股东损益(元) -11,128,620.953,082,866.646,112,448.32-153,111,303.98-84,419,133.32-73,075,772.23-2,866,793.55
 扣除非经常性损益后的净利润(元) 544,531,450.78270,475,996.0056,677,250.28-1,378,079,973.60-512,007,860.22-440,325,695.22-13,686,317.97
七、每股收益
 一、基本每股收益(元) 0.410.200.04-1.01-0.37-0.33-0.01
 二、稀释每股收益(元) 0.410.200.04-1.01-0.37-0.33-0.01
八、其他综合收益(元) 3,086,398.37-40,712,722.89-52,610,170.5849,694,692.882,814,083.8322,490,620.319,848,219.07
 归属于母公司股东的其他综合收益(元) 3,877,421.26-40,833,921.20-52,610,170.5849,694,692.883,095,526.6121,100,559.699,848,219.07
 归属于少数股东的其他综合收益(元) -791,022.89121,198.31---281,442.781,390,060.62-
九、综合收益总额(元) 557,582,167.95239,053,067.697,566,038.59-1,466,732,641.44-585,987,155.61-497,873,788.06-7,300,826.24
 归属于母公司所有者的综合收益总额(元) 569,501,811.79235,849,002.741,453,590.27-1,313,621,337.46-501,286,579.51-426,188,076.45-4,434,032.69
 归属于少数股东的综合收益总额(元) -11,919,643.843,204,064.956,112,448.32-153,111,303.98-84,700,576.10-71,685,711.61-2,866,793.55
公告日期 2024-10-292024-08-292024-04-302024-04-292023-10-312023-08-262023-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院